ReviewCardiovascular diabetology. Endocrinology reports2026
Risk stratification in diabetic ankle fractures: a systematic review of reviews and proposal of the MADRAS scoring system.
Review in Cardiovascular diabetology. Endocrinology reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDiabetic ankle fractures present significant clinical challenges, with higher rates of complications including infection, non-union, Charcot neuroarthropathy, and amputation compared to non-diabetic patients. Despite this burden, no universally accepted guidelines exist for risk stratification and management. The Adelaide Fracture in the Diabetic Ankle (AFDA) score was proposed in 2014 but has limitations including uniform weighting of risk factors and exclusion of local injury characteristics. This systematic review of reviews aimed to synthesise current evidence and develop an updated, evidence-based risk stratification tool.
methodsA comprehensive search of Embase, PubMed, and Web of Science was conducted. Eligible studies included systematic and narrative reviews examining outcomes, risk factors, or interventions for diabetic ankle fractures. Risk of bias was assessed using the ROBIS tool. Data were synthesised narratively, and an evidence-informed, consensus-based scoring system was developed by translating observed effect sizes from the included reviews into weighted risk scores.
resultsThirteen reviews were included. Complicated diabetes, particularly peripheral neuropathy, peripheral arterial disease, and prior Charcot neuroarthropathy, emerged as the strongest predictors of adverse outcomes. Non-operative management of unstable fractures was associated with significantly higher complication rates. Based on these findings, we propose the Manchester Ankle Fracture Diabetic Risk Assessment Score (MADRAS), incorporating weighted systemic host factors, local injury characteristics, and modifiable patient factors across a 17-point scale stratifying patients into four management tiers: low risk (0-2), moderate risk (3-5), high risk (6), and very high risk (≥ 7).
conclusionMADRAS addresses limitations of existing frameworks by incorporating evidence-based weightings and local injury factors. Prospective external validation is required before widespread clinical adoption; until then, MADRAS should be regarded as a decision-support tool. This tool may assist clinicians in systematic risk stratification and surgical decision-making for diabetic ankle fractures.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.